UBS Upgrades Colfax to Buy, PT Raised to $43

UBS has upgraded Colfax Corporation CFX from Neutral to Buy and has raised the price target from $24 to $43.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: UpgradesPrice TargetAnalyst RatingsUBS Investment Research
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!